Maja Suter
Career history of Maja Suter
Former positions of Maja Suter
Companies | Position | Start | End |
---|---|---|---|
CELLnTec Advanced Cell Systems AG
CELLnTec Advanced Cell Systems AG Pharmaceuticals: GenericHealth Technology CELLnTec Advanced Cell Systems AG develops methods for the cultivation of epithelial cells. It offers progenitor cell targeted (PCT) media for the isolation and retention of undifferentiated cells, and non-PCT media for differentiation in 2D or 3D culture; and primary human and long-term animal cells. The firm also offers various products for the culture of primary epidermal keratinocytes, airway epithelium cells, primary epithelial cells from human and a range of animal species, primary corneal and limbal epithelial cells from human and mouse, primary fibroblasts from human and a range of animal species, primary prostate epithelial cells from human and a range of animal species, and other products. The company was founded by Peter Girling, Maja Suter and Eliane Müller in 2002 and is headquartered in Bern, Switzerland. | Director/Board Member | 30/04/2002 | - |
Founder | 30/04/2002 | - |
Statistics
International
Switzerland | 2 |
Operational
Director/Board Member | 1 |
Founder | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
CELLnTec Advanced Cell Systems AG
CELLnTec Advanced Cell Systems AG Pharmaceuticals: GenericHealth Technology CELLnTec Advanced Cell Systems AG develops methods for the cultivation of epithelial cells. It offers progenitor cell targeted (PCT) media for the isolation and retention of undifferentiated cells, and non-PCT media for differentiation in 2D or 3D culture; and primary human and long-term animal cells. The firm also offers various products for the culture of primary epidermal keratinocytes, airway epithelium cells, primary epithelial cells from human and a range of animal species, primary corneal and limbal epithelial cells from human and mouse, primary fibroblasts from human and a range of animal species, primary prostate epithelial cells from human and a range of animal species, and other products. The company was founded by Peter Girling, Maja Suter and Eliane Müller in 2002 and is headquartered in Bern, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Maja Suter
- Experience